Ignite Creation Date:
2024-05-06 @ 12:37 PM
Last Modification Date:
2024-10-26 @ 1:01 PM
Study NCT ID:
NCT03800160
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-05-13
First Post:
2018-05-14
Brief Title:
Greater China Metabolic and Bariatric Surgery Database
Sponsor:
Beijing Friendship Hospital
Organization:
Beijing Friendship Hospital
Study Overview
Official Title:
Greater China Metabolic and Bariatric Surgery Database
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Metabolic surgery as a recognition treatment option for patients with clinical morbid obesity is gaining increasing appreciation In addition to substantial weight loss emerging studies have highlighted that metabolic surgery can substantially ameliorate obesity-related metabolic diseases including but not limited to type 2 diabetes mellitus T2DM hypertension dyslipidemia obstructive sleep apnea-hypopnea syndrome OSAHS and polycystic ovary syndrome PCOSin severely obese patients However further investigations with larger sample size and longer observation time still needed to clarity the efficacy and safety of metabolic surgery in Chinese patients with obesity and encouraging future research in this field
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None